Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	7/15/2003 3:16:09 AM
From: nigel bates	Read Replies (1) of 598

Tularik's Ling on 'Which Genome' (posted elsewhere by tuck) : dddmag.com Companies looking to mine the human genome for unique, druggable targets will have greater success using the sequence provided by the International Human Genome Sequencing Consortium (HGSC) than the proprietary, and more expensive, version offered by Celera Genomics Group, Rockville, Md., according to research published by Tularik Inc., South San Francisco, Calif., and the Genomic Institute of Novartis Research Foundation (GNF), San Diego...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next